NHS will drop Palantir in 2029, not 2027, ministers confirm
Ministers will end the NHS's Palantir contract in 2029, extending it two years past a 2027 break clause to give UK firms time to replace the federated data platform.

Why it matters
- The DHSC will end Palantir's NHS contract in 2029, extending it two years rather than using a 2027 break clause.
- NHS England agreed the federated data platform contract with Palantir in 2023.
- NHS England deleted its claim that 137 trusts benefited from the FDP after the Guardian found 29 used it never or rarely.
- Health minister James Frith said British tech firms will be invited to bid to replace Palantir.
- Amnesty International and Just Treatment had urged ministers to trigger the break clause in February.
The NHS in England will end its contract with Palantir in 2029 — two years later than a break clause allowed — because ministers want time to line up British companies to replace the US firm.
The Department of Health and Social Care (DHSC) has decided to extend Palantir's contract to run the federated data platform (FDP) for two more years. That software links different healthcare providers across the NHS. The deal included a break clause that would have let ministers axe the contract next spring. They chose not to use it.
Health minister James Frith told MPs the relationship would end in 2029. The goal, he said, is to boost public trust in NHS tech, end the health service's "over-dependence" on one supplier, and let UK companies start providing crucial digital infrastructure. The DHSC will select UK tech firms to replace Palantir in the meantime.
Why does the 2029 date matter?
The decision puts a firm end date on one of the most contested technology relationships in British public services. Ministers have faced growing pressure to sever ties with Palantir, which is run by Donald Trump-supporting US tech billionaire Peter Thiel. Campaign groups such as Amnesty International and Just Treatment have urged ministers to activate the break clause in February — a clause in the contract NHS England agreed with Palantir in 2023.
Labour and Liberal Democrat MPs criticised the decision to give Palantir two more years.
"My committee has repeatedly called on the government to exercise the 2027 break clause in Palantir's federated data platform contract with the NHS," said Chi Onwurah, chair of the Commons science and technology select committee.
"It's deeply disappointing to hear that it won't do so and is instead choosing to extend the contract for two years, during which time it says it will procure a UK-based supplier."
Liberal Democrat MP Martin Wrigley went further. "After months of campaigning by the Liberal Democrats, the government has finally admitted that the Palantir contract has to end," he said.
"However, ministers have kicked the can down the road to March 2029. That leaves a company co-founded by Trump ally Peter Thiel, and criticised by human rights groups over its work with ICE [the US Immigration and Customs Enforcement agency], holding the keys to our health data for years to come."
How much is the platform actually used?
Scepticism about the FDP runs deep inside the NHS itself. Many NHS care trusts have declined to use the platform. Doubt is widespread in the service over whether the software is as good as Palantir insists.
The numbers tell their own story. NHS England last week deleted a claim from its website that 137 trusts were benefiting from the FDP. The removal came after the Guardian disclosed that 29 of those trusts were using it never or rarely.
That gap — between claimed adoption and actual use — sits at the heart of the political fight. Frith acknowledged the trust problem directly when he addressed MPs.
"The current contract will remain for two years, before coming to an end," he said.
The DHSC will soon invite British tech outfits to bid to be part of whoever replaces Palantir. "A process this important must command public trust as well as clinical confidence," Frith added — a tacit admission that many hospital bosses and doctors are sceptical about Palantir's claimed benefits.
What did critics and supporters say?
Ben Coleman, a Labour member of the Commons health select committee, last week urged ministers to replace Palantir with a group of British firms. He welcomed the direction of travel, with conditions.
"I'm glad the government is ending reliance on a single supplier and shaking off the Palantir albatross. This must be done without disrupting patient care or creating new dependence [on a new single supplier]," Coleman said.
Amnesty International framed the outcome as a win for sustained pressure. The decision was "a victory for healthcare workers, patients and campaigners who refused to give up," the organisation said.
Tom Guha, Amnesty's crisis campaigner, pointed to Palantir's wider record.
"Doctors and nurses … should never have to work in a health service that partners with a company supporting a military committing genocide," Guha said.
"Palantir has openly acknowledged supporting Israel's military in 'war-related missions', while Israel is committing genocide against Palestinians in Gaza. 'First, do no harm' should apply not just to NHS staff, but to the companies the NHS contracts with."
What happens between now and 2029?
Three things will shape the next two years:
- The procurement race. The DHSC will soon open bidding to British tech firms wanting to supply the replacement infrastructure. The scale of that task — replicating a platform meant to link providers across the entire English health system — will test whether UK suppliers can step up.
- Continued scrutiny of adoption. With 29 trusts using the FDP never or rarely, and NHS England forced to retract its 137-trust claim, watchdogs and journalists will keep measuring the gap between marketing and reality.
- Political pressure. Onwurah's committee has already flagged the 2027 break clause as its preferred route. The 2029 extension gives critics a long window to argue the transition should move faster.
The stakes reach beyond one contract. Whoever wins the replacement work will hold the plumbing that connects NHS data across England — infrastructure with enormous commercial and clinical value. Frith's warning about public trust and clinical confidence signals that the DHSC knows the next procurement will be judged as much on process as on technology.
By setting a 2029 end date, ministers have bought themselves time to build a British alternative — and handed Palantir's critics two more years of ammunition in the meantime.
Source: theguardian.com
More from Elena Vasquez
Show full bio
Market editor covering technology and product news in artificial intelligence and machine learning at AI In Context.
708 articles
Related articles
- More Than 44,000 File Legal Objections to Palantir-Run NHS Data Platform
- 29 NHS trusts listed as Palantir beneficiaries say they don't use the platform
- Australia's Agencies Ordered to Audit Legacy Tech After OpenAI Medicare Breach
- Oura to Acquire Counsel Health for $625 Million in Cash
- OpenAI signs UK government partnership, pledges London expansion